This early-phase trial is testing a special PET imaging agent that targets a protein called IFN-gamma to see if it can find lung cancer tumors and show how well they respond to immunotherapy. Six adults with untreated non-small cell lung cancer will get a PET scan before starting…
Phase: PHASE1 • Sponsor: Nerissa T. Viola • Aim: Diagnosis
Last updated May 14, 2026 12:05 UTC